<DOC>
	<DOCNO>NCT01602341</DOCNO>
	<brief_summary>The purpose study determine safety efficacy AN2728 Topical Ointment , 2 % 0.5 % , administer day ( QD ) twice day ( BID ) , treatment adolescent atopic dermatitis ( AD )</brief_summary>
	<brief_title>Efficacy Safety AN2728 Topical Ointment Treat Adolescents With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female 12 17 year age , inclusive Clinical diagnosis atopic dermatitis ( accord criterion Hanifin Rajka ) Total body surface area ( BSA ) atopic dermatitis involvement â‰¤35 % Presence two comparable target lesion Willing able comply study instruction commit attend visit Females childbearing potential must use highly effective method birth control . Males partner childbearing potential inform participation clinical study use highly effective method birth control study . Parent/guardian ability understand , agree sign study Informed Consent Form ( ICF ) prior initiation protocolrelated procedure ; subject ability give assent Significant confounding condition assess study doctor Unstable actively infect AD Active potentially recurrent dermatologic condition atopic dermatitis target lesion area may confound evaluation History evidence allergy require acute chronic treatment ( except seasonal allergic rhinitis ) Concurrent recent use certain topical systemic medication phototherapy without sufficient washout period Treatment type cancer ( except squamous cell carcinoma , basal cell carcinoma , carcinoma situ skin , curatively treated cryosurgery surgical excision ) within last 5 year Current pregnancy lactation , intent become pregnant study Known sensitivity component study drug Participated trial investigational drug device within 30 day participation research study concurrent study Participated previous AN2728 clinical study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>atopic dermatitis</keyword>
</DOC>